Lab Members
Luis Ruffolo, M.D.
Principal Investigator
Dr. Ruffolo is a hepatopancreatobiliary surgical oncologist at University of Rochester Medicine and Wilmot Cancer Institute. He cares for patients with cancers of the pancreas, bile ducts and liver, including those needing a Whipple procedure, liver resection or other complex cancer operations, and sees patients in English and Spanish. He completed surgical oncology training at Memorial Sloan Kettering Cancer Center. His research focuses on tumor immunology: how macrophages and stromal cells shut down T-cell responses in pancreatic cancer, cholangiocarcinoma and liver metastases, and why liver metastases resist immune checkpoint inhibitors. His first-author work in Gut showed that GM-CSF drives suppressive tumor-associated macrophages in cholangiocarcinoma and that blocking it restores anti-tumor T-cell immunity in mouse models. He holds a Wilmot Cancer Institute Physician-Scientist Fellowship.
Brian A. Belt, J.D., M.A.
Scientific Co-PI
Brian leads the lab’s scientific operations and has spent many years training surgeon-scientists in tumor immunology at URochester Medicine. Surgeons he has trained in the lab include Tim Nywening, Matt Porembka, Dominick Sanford, John Mitchem, Roheena Panni, Luis Ruffolo, Nicholas Ullman and Paul Burchard.
Rachel Jewell
Lab Manager
Rachel manages the lab’s day-to-day operations, including mouse colonies, tissue processing and regulatory compliance. She has contributed to the lab’s published work on cholangiocarcinoma and the tumor microenvironment.
Benjamin Dale, M.D.
Research Fellow
Ben leads projects that bridge bioinformatics and wet-bench work. His research focuses on how resident liver macrophages (Kupffer cells) and bone marrow-derived macrophages each contribute to the growth and progression of liver metastases. He has co-authored the lab’s work on GM-CSF and lysyl oxidase in cholangiocarcinoma.